Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coa...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45340d6bf79e49b5b1900d5b2ff1185a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:45340d6bf79e49b5b1900d5b2ff1185a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:45340d6bf79e49b5b1900d5b2ff1185a2021-11-14T09:00:14ZResults of early panretinal laser coagulation in patients with type 1 diabetes mellitus2072-03512072-037810.14341/2072-0351-6025https://doaj.org/article/45340d6bf79e49b5b1900d5b2ff1185a2010-03-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6025https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coagulation after subtenon administrationof triamcinolone (40 mg) under ultrasonic control. Results. PLC at the stage of severe non-proliferative DR stabilized its development in 35% of the patients and caused its reverse development withresolution of oedema and intraretinal hemorrhage, normalization of vein diameter, and improvement of visual acuity in 30%. In 35% of these casesPLC caused neovascularization within 1.6?0.9 years after treatment. Reverse development of DR after PLC was documented in 46.3% cases withearly proliferative DR but stabilization of DR occurred rarer than in the previous group (14.6%) and hemorrhage into the vitreous body more frequently(12 cases in 41 and 2 in 40 respectively, p = 0.0007). Patients with severe non-proliferative DR tended to have reduced requirement for vitrectomyafter PLC compared with those having early proliferative DR (1 case of 40 and 6 of 41, p = 0.052).Conclusion: The above results suggest the necessity of early PLC in DM1 patients.Dmitriy Sergeevich AtarshchikovVladimir Yur'evich EvgrafovYury Evgen'evich BatmanovEndocrinology Research Centrearticlediabetic retinopathypanretinal laser coagulationtriamcinolonediabetes mellitusNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 13, Iss 1, Pp 112-115 (2010) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
diabetic retinopathy panretinal laser coagulation triamcinolone diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
diabetic retinopathy panretinal laser coagulation triamcinolone diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627 Dmitriy Sergeevich Atarshchikov Vladimir Yur'evich Evgrafov Yury Evgen'evich Batmanov Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus |
description |
Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coagulation after subtenon administrationof triamcinolone (40 mg) under ultrasonic control. Results. PLC at the stage of severe non-proliferative DR stabilized its development in 35% of the patients and caused its reverse development withresolution of oedema and intraretinal hemorrhage, normalization of vein diameter, and improvement of visual acuity in 30%. In 35% of these casesPLC caused neovascularization within 1.6?0.9 years after treatment. Reverse development of DR after PLC was documented in 46.3% cases withearly proliferative DR but stabilization of DR occurred rarer than in the previous group (14.6%) and hemorrhage into the vitreous body more frequently(12 cases in 41 and 2 in 40 respectively, p = 0.0007). Patients with severe non-proliferative DR tended to have reduced requirement for vitrectomyafter PLC compared with those having early proliferative DR (1 case of 40 and 6 of 41, p = 0.052).Conclusion: The above results suggest the necessity of early PLC in DM1 patients. |
format |
article |
author |
Dmitriy Sergeevich Atarshchikov Vladimir Yur'evich Evgrafov Yury Evgen'evich Batmanov |
author_facet |
Dmitriy Sergeevich Atarshchikov Vladimir Yur'evich Evgrafov Yury Evgen'evich Batmanov |
author_sort |
Dmitriy Sergeevich Atarshchikov |
title |
Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus |
title_short |
Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus |
title_full |
Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus |
title_fullStr |
Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus |
title_full_unstemmed |
Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus |
title_sort |
results of early panretinal laser coagulation in patients with type 1 diabetes mellitus |
publisher |
Endocrinology Research Centre |
publishDate |
2010 |
url |
https://doaj.org/article/45340d6bf79e49b5b1900d5b2ff1185a |
work_keys_str_mv |
AT dmitriysergeevichatarshchikov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus AT vladimiryurevichevgrafov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus AT yuryevgenevichbatmanov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus |
_version_ |
1718429644146868224 |